|
|
|
PEDF, protein that inhibits blood vessel growth in the eye, is licensed as possible gene therapy candidate to prevent blindness
An eye protein that blocks excessive blood vessel growth will be developed as a possible candidate for gene therapy to prevent blindness in individuals with diabetic retinopathy and macular degeneration, the leading cause of blindness in the Western world. Contact:
Elizabeth Crown
e-crown@northwestern.edu
312-503-8928
Northwestern University
Message posted by: Wouter Kalle
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|